Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Trando

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Ejhaem|January 21, 2026
Refractory Periorbital Necrobiotic Xanthogranuloma Treated With Plasma Cell-Directed TherapyAaron Trando, Ah-Reum Jeong, Aaron M Goodman
The Neurologist|November 29, 2021
Simulation-Based Training Improves Fellows' Competence in Brain Death Discussion and DeclarationPatrick M Chen, Aaron Trando, Jamie Nicole LaBuzetta
British Journal of Haematology|June 26, 2023
First use of ibrutinib for the treatment of post-transplant central nervous system graft-versus-host diseaseAaron Trando, Anastasie Dunn-Pirio, Divya Koura, et al.
Acta Oncologica (Stockholm, Sweden)|August 15, 2024
Radiation-associated cutaneous mastocytosis: a case report and review of the literatureAaron Trando, Karen M Austin, Brian Hinds, et al.
Biomedicines|January 25, 2025
Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution ExperienceAaron Trando, Farid Ghamsari, Philip Yeung, et al.
Cancers|September 28, 2023
Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution ExperienceAaron Trando, Anna Ter-Zakarian, Phillip Yeung, et al.
Neurocritical Care|April 15, 2024
Survivorship After Neurocritical Care: A Scoping Review of Outcomes Beyond Physical StatusJamie Nicole LaBuzetta, Dale N Bongbong, Eric Mlodzinski, et al.
The Oncologist|September 5, 2024
Evaluating early intervention in smoldering myeloma clinical trials: a systematic reviewApoorva Kakkilaya, Aaron Trando, Edward R Scheffer Cliff, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Ejhaem|January 21, 2026
Refractory Periorbital Necrobiotic Xanthogranuloma Treated With Plasma Cell-Directed TherapyAaron Trando, Ah-Reum Jeong, Aaron M Goodman
The Neurologist|November 29, 2021
Simulation-Based Training Improves Fellows' Competence in Brain Death Discussion and DeclarationPatrick M Chen, Aaron Trando, Jamie Nicole LaBuzetta
British Journal of Haematology|June 26, 2023
First use of ibrutinib for the treatment of post-transplant central nervous system graft-versus-host diseaseAaron Trando, Anastasie Dunn-Pirio, Divya Koura, et al.
Acta Oncologica (Stockholm, Sweden)|August 15, 2024
Radiation-associated cutaneous mastocytosis: a case report and review of the literatureAaron Trando, Karen M Austin, Brian Hinds, et al.
Biomedicines|January 25, 2025
Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution ExperienceAaron Trando, Farid Ghamsari, Philip Yeung, et al.
Cancers|September 28, 2023
Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution ExperienceAaron Trando, Anna Ter-Zakarian, Phillip Yeung, et al.
Neurocritical Care|April 15, 2024
Survivorship After Neurocritical Care: A Scoping Review of Outcomes Beyond Physical StatusJamie Nicole LaBuzetta, Dale N Bongbong, Eric Mlodzinski, et al.
The Oncologist|September 5, 2024
Evaluating early intervention in smoldering myeloma clinical trials: a systematic reviewApoorva Kakkilaya, Aaron Trando, Edward R Scheffer Cliff, et al.
Pageof 1